Michael D Fabrizio
Overview
Explore the profile of Michael D Fabrizio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McKay R, Hafron J, Ferro C, Wilfehrt H, Fitch K, Flanders S, et al.
Adv Ther
. 2020 Oct;
37(12):4910-4929.
PMID: 33029725
Introduction: Since sipuleucel-T approval in 2010, the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) now includes the androgen-receptor signaling pathway inhibitors (ASPIs) abiraterone acetate or enzalutamide. In 2013 and...
2.
Lin D, Zheng Y, McKenney J, Brown M, Lu R, Crager M, et al.
J Clin Oncol
. 2020 Mar;
38(14):1549-1557.
PMID: 32130059
Purpose: The 17-gene Onco DX Genomic Prostate Score (GPS) test predicts adverse pathology (AP) in patients with low-risk prostate cancer treated with immediate surgery. We evaluated the GPS test as...
3.
Newcomb L, Zheng Y, Faino A, Bianchi-Frias D, Cooperberg M, Brown M, et al.
Prostate Cancer Prostatic Dis
. 2019 Jan;
22(3):438-445.
PMID: 30664734
Background: For men on active surveillance for prostate cancer, biomarkers may improve prediction of reclassification to higher grade or volume cancer. This study examined the association of urinary PCA3 and...
4.
Cooperberg M, Brooks J, Faino A, Newcomb L, Kearns J, Carroll P, et al.
Eur Urol
. 2018 Feb;
74(2):211-217.
PMID: 29433975
Background: For men on active surveillance for prostate cancer, utility of prostate-specific antigen (PSA) kinetics (PSAk) in predicting pathologic reclassification remains controversial. Objective: To develop prediction methods for utilizing serial...
5.
Hubosky S, Davis J, Given R, Fabrizio M
J Robot Surg
. 2014 Dec;
1(1):85-8.
PMID: 25484941
Robotically assisted laparoscopic radical prostatectomy (RaLRP) has become an alternative surgical treatment option for patients with localized prostate cancer. Rare anatomic variations result in modification of established techniques. We describe...
6.
Watson J, Behnke M, Fabrizio M, McCune T
J Endourol
. 2013 Oct;
27(12):1525-9.
PMID: 24134317
Background And Purpose: There is a paucity of prospective long-term data on living kidney donor (LKD) quality of life (QoL). The Living Organ Donor Network (LODN) database follows donors longitudinally...
7.
Patel V, Coelho R, Rocco B, Orvieto M, Sivaraman A, Palmer K, et al.
J Urol
. 2011 Jun;
186(2):511-6.
PMID: 21680001
Purpose: Positive surgical margins are an independent predictive factor for biochemical recurrence after radical prostatectomy. We analyzed the incidence of and associative factors for positive surgical margins in a multi-institutional...
8.
Malcolm J, Fabrizio M, Barone B, Given R, Lance R, Lynch D, et al.
J Urol
. 2010 Mar;
183(5):1822-8.
PMID: 20303100
Purpose: Health related quality of life concerns factor prominently in prostate cancer management. We describe health related quality of life impact and recovery profiles of 4 commonly used operative treatments...
9.
Malcolm J, Berry T, Williams M, Logan J, Given R, Lance R, et al.
J Endourol
. 2009 May;
23(6):907-11.
PMID: 19456244
Background And Purpose: While partial nephrectomy remains the gold standard for the management of most small renal masses, increasing experience with renal cryoablation has suggested a viable alternative with a...
10.
Schwab 2nd C, Vingan H, Fabrizio M
J Endourol
. 2008 May;
22(6):1247-50.
PMID: 18484874
Purpose: To determine the usefulness of adrenal vein sampling (AVS) in patients referred for surgical management of primary aldosteronism (PA). Patients And Methods: From July 2001 to September 2006, 12...